Cargando…

Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals

HIV-1 infection induces a chronic inflammatory environment not restored by suppressive antiretroviral therapy (ART). As of today, the effect of viral suppression and immune reconstitution in people living with HIV-1 (PLWH) has been well described but not completely understood. Herein, we show how PL...

Descripción completa

Detalles Bibliográficos
Autores principales: Svensson Akusjärvi, Sara, Krishnan, Shuba, Jütte, Bianca B., Ambikan, Anoop T., Gupta, Soham, Rodriguez, Jimmy Esneider, Végvári, Ákos, Sperk, Maike, Nowak, Piotr, Vesterbacka, Jan, Svensson, J. Peter, Sönnerborg, Anders, Neogi, Ujjwal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008025/
https://www.ncbi.nlm.nih.gov/pubmed/35418589
http://dx.doi.org/10.1038/s42003-022-03315-x
_version_ 1784686961095606272
author Svensson Akusjärvi, Sara
Krishnan, Shuba
Jütte, Bianca B.
Ambikan, Anoop T.
Gupta, Soham
Rodriguez, Jimmy Esneider
Végvári, Ákos
Sperk, Maike
Nowak, Piotr
Vesterbacka, Jan
Svensson, J. Peter
Sönnerborg, Anders
Neogi, Ujjwal
author_facet Svensson Akusjärvi, Sara
Krishnan, Shuba
Jütte, Bianca B.
Ambikan, Anoop T.
Gupta, Soham
Rodriguez, Jimmy Esneider
Végvári, Ákos
Sperk, Maike
Nowak, Piotr
Vesterbacka, Jan
Svensson, J. Peter
Sönnerborg, Anders
Neogi, Ujjwal
author_sort Svensson Akusjärvi, Sara
collection PubMed
description HIV-1 infection induces a chronic inflammatory environment not restored by suppressive antiretroviral therapy (ART). As of today, the effect of viral suppression and immune reconstitution in people living with HIV-1 (PLWH) has been well described but not completely understood. Herein, we show how PLWH who naturally control the virus (PLWH(EC)) have a reduced proportion of CD4(+)CCR6(+) and CD8(+)CCR6(+) cells compared to PLWH on suppressive ART (PLWH(ART)) and HIV-1 negative controls (HC). Expression of CCR2 was reduced on both CD4(+), CD8(+) and classical monocytes in PLWH(EC) compared to PLWH(ART) and HC. Longer suppressive therapy, measured in the same patients, decreased number of cells expressing CCR2 on all monocytic cell populations while expression on CD8(+) T cells increased. Furthermore, the CD4(+)CCR6(+)/CCR6(−) cells exhibited a unique proteomic profile with a modulated energy metabolism in PLWH(EC) compared to PLWH(ART) independent of CCR6 status. The CD4(+)CCR6(+) cells also showed an enrichment in proteins involved in apoptosis and p53 signalling in PLWH(EC) compared to PLWH(ART), indicative of increased sensitivity towards cell death mechanisms. Collectively, this data shows how PLWH(EC) have a unique chemokine receptor profile that may aid in facilitating natural control of HIV-1 infection.
format Online
Article
Text
id pubmed-9008025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90080252022-04-27 Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals Svensson Akusjärvi, Sara Krishnan, Shuba Jütte, Bianca B. Ambikan, Anoop T. Gupta, Soham Rodriguez, Jimmy Esneider Végvári, Ákos Sperk, Maike Nowak, Piotr Vesterbacka, Jan Svensson, J. Peter Sönnerborg, Anders Neogi, Ujjwal Commun Biol Article HIV-1 infection induces a chronic inflammatory environment not restored by suppressive antiretroviral therapy (ART). As of today, the effect of viral suppression and immune reconstitution in people living with HIV-1 (PLWH) has been well described but not completely understood. Herein, we show how PLWH who naturally control the virus (PLWH(EC)) have a reduced proportion of CD4(+)CCR6(+) and CD8(+)CCR6(+) cells compared to PLWH on suppressive ART (PLWH(ART)) and HIV-1 negative controls (HC). Expression of CCR2 was reduced on both CD4(+), CD8(+) and classical monocytes in PLWH(EC) compared to PLWH(ART) and HC. Longer suppressive therapy, measured in the same patients, decreased number of cells expressing CCR2 on all monocytic cell populations while expression on CD8(+) T cells increased. Furthermore, the CD4(+)CCR6(+)/CCR6(−) cells exhibited a unique proteomic profile with a modulated energy metabolism in PLWH(EC) compared to PLWH(ART) independent of CCR6 status. The CD4(+)CCR6(+) cells also showed an enrichment in proteins involved in apoptosis and p53 signalling in PLWH(EC) compared to PLWH(ART), indicative of increased sensitivity towards cell death mechanisms. Collectively, this data shows how PLWH(EC) have a unique chemokine receptor profile that may aid in facilitating natural control of HIV-1 infection. Nature Publishing Group UK 2022-04-13 /pmc/articles/PMC9008025/ /pubmed/35418589 http://dx.doi.org/10.1038/s42003-022-03315-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Svensson Akusjärvi, Sara
Krishnan, Shuba
Jütte, Bianca B.
Ambikan, Anoop T.
Gupta, Soham
Rodriguez, Jimmy Esneider
Végvári, Ákos
Sperk, Maike
Nowak, Piotr
Vesterbacka, Jan
Svensson, J. Peter
Sönnerborg, Anders
Neogi, Ujjwal
Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
title Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
title_full Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
title_fullStr Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
title_full_unstemmed Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
title_short Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
title_sort peripheral blood cd4(+)ccr6(+) compartment differentiates hiv-1 infected or seropositive elite controllers from long-term successfully treated individuals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008025/
https://www.ncbi.nlm.nih.gov/pubmed/35418589
http://dx.doi.org/10.1038/s42003-022-03315-x
work_keys_str_mv AT svenssonakusjarvisara peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT krishnanshuba peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT juttebiancab peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT ambikananoopt peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT guptasoham peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT rodriguezjimmyesneider peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT vegvariakos peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT sperkmaike peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT nowakpiotr peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT vesterbackajan peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT svenssonjpeter peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT sonnerborganders peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals
AT neogiujjwal peripheralbloodcd4ccr6compartmentdifferentiateshiv1infectedorseropositiveelitecontrollersfromlongtermsuccessfullytreatedindividuals